1.
Bedoya-Trujillo LN, Bedoya-Trujillo PN. Case report: pembrolizumab-induced Type 1 diabetes mellitus in a patient with lung adenocarcinoma. rcedm [Internet]. 2021 Mar. 19 [cited 2022 Jan. 28];7(3):188-92. Available from: http://www.revistaendocrino.org/index.php/rcedm/article/view/632